Researchers identify a decline in a cellular cleanup process that allows aging cells to accumulate, disrupt tissues, and potentially worsen age-related diseases.

As the body ages, its ability to remove damaged and dysfunctional cells gradually weakens. New research suggests that a decline in a vital cellular maintenance process may be one reason these cells persist, contributing to inflammation, impaired tissue repair, and age-related diseases.

The study, titled “Decline of Chaperone-Mediated Autophagy in Aging Impairs Macrophage Clearance of Senescent Cells,” examines how the loss of a process called chaperone-mediated autophagy (CMA) affects the accumulation and removal of senescent cells. The findings point to a potential new approach to helping aging tissues maintain their health and function.

When Aging Cells Become a Problem

Senescent cells are cells that have stopped dividing in response to stress, damage, or the natural limits of repeated cell replication. Although they no longer reproduce, they remain active and release a mixture of inflammatory and growth-related signals.

In younger individuals, these cells can serve useful purposes. They help coordinate tissue repair and regeneration and can alert the immune system to cells that may pose a cancer risk. The immune system normally removes them once their job is done.

However, this clearance process becomes less efficient with age. As senescent cells accumulate, the substances they release can promote inflammation, encourage neighboring cells to become senescent, and interfere with normal tissue function.

Even a relatively small population of lingering senescent cells can have widespread effects because of their persistent signaling activity.

The Role of the Cellular Cleanup System

Researchers focused on chaperone-mediated autophagy, a process that helps cells maintain their health by identifying and breaking down specific proteins that are damaged, unwanted, or no longer needed.

The process relies on specialized chaperone proteins that identify selected protein targets and guide them to lysosomes, the cell’s recycling compartments. There, the proteins are broken down and their components can be reused.

CMA activity declines with age in many tissues. Previous research has linked problems with this process to several age-related conditions, including neurodegenerative diseases, metabolic disorders, and atherosclerosis.

The new study reveals that this decline may also contribute to the persistence of senescent cells by affecting both the cells themselves and the immune cells responsible for removing them.

How Senescent Cells Disrupt Their Own Clearance

The researchers found that cells with impaired CMA developed characteristics similar to those seen in senescent cells from older organisms. These changes involved their proteins, metabolism, and the signals they released.

Their secretions, known as the senescence-associated secretory phenotype, had two important effects: they encouraged neighboring cells to become senescent and interfered with CMA activity in macrophages.

Macrophages are immune cells that help protect the body by engulfing and removing unwanted material, including senescent cells. When their CMA activity is impaired, their ability to clear these cells is reduced.

This creates a potentially damaging cycle: aging cells release signals that promote further senescence and weaken the immune system’s ability to remove them, allowing more senescent cells to persist.

The findings suggest that the problem is not simply that the aging immune system becomes less effective. Changes within senescent cells themselves may also contribute to the failure of immune clearance.

Experiments Point to a Potential Treatment Strategy

The study’s findings were supported by experiments in mice.

When researchers blocked CMA specifically in macrophages, senescent cells accumulated in greater numbers. The intervention also delayed the resolution of senescence during wound healing, suggesting that the process plays an important role in restoring tissue health after injury.

In contrast, pharmacologically activating CMA reduced the burden of senescent cells in aged mice. Researchers also observed reduced disease severity in a mouse model of pulmonary fibrosis, a condition characterized by scarring of lung tissue.

These results suggest that boosting CMA activity could help the body manage senescent cells more effectively. However, the findings remain preclinical and do not establish that the same approach will be safe or effective in humans.

A New Direction for Aging Research

The study highlights chaperone-mediated autophagy as a potential target for therapies designed to improve cellular maintenance and support the removal of senescent cells.

Rather than focusing exclusively on eliminating senescent cells, future treatments might also aim to restore the processes that help the body recognize and clear them naturally.

Further research will be needed to determine how CMA can be safely activated, which molecular targets are most promising, and whether these findings can be translated into effective treatments for age-related diseases.

By revealing how declining cellular maintenance can disrupt the relationship between aging cells and the immune system, the research offers new insight into why senescent cells accumulate with age and identifies a promising avenue for future efforts to preserve tissue health and improve healthy aging.